Please assess the completion status of the following clinical trial:

Trial Title: Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 6 weeks old infants~* The infant should be healthy and not have any serious malformations~* The mother should be healthy and not have any serious disorders or use any daily medications~* The mother should have an ordinary omnivorous diet~Exclusion Criteria:~* If there are evidence of serious infant disease during the study period, the infant should be excluded from the study

- Gender: ALL
- Minimum Age: 4 Weeks
- Maximum Age: 4 Months
- Healthy Volunteers: t

Study Arms:
- Cobalamin (Type: EXPERIMENTAL): An intramuscular injection of 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma, Norway)
- No intervention (Type: NO_INTERVENTION): No intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).